164 related articles for article (PubMed ID: 21619545)
21. Bioresorbable Vascular Scaffolds for Patients With In-Stent Restenosis: The RIBS VI Study.
Alfonso F; Cuesta J; Pérez-Vizcayno MJ; García Del Blanco B; Rumoroso JR; Bosa F; Pérez de Prado A; Masotti M; Moreno R; Cequier A; Gutiérrez H; García Touchard A; López-Mínguez JR; Zueco J; Martí V; Velázquez M; Morís C; Bastante T; García-Guimaraes M; Rivero F; Fernández C;
JACC Cardiovasc Interv; 2017 Sep; 10(18):1841-1851. PubMed ID: 28866036
[TBL] [Abstract][Full Text] [Related]
22. Restenosis following implantation of bare metal coronary stents: pathophysiology and pathways involved in the vascular response to injury.
Scott NA
Adv Drug Deliv Rev; 2006 Jun; 58(3):358-76. PubMed ID: 16733073
[TBL] [Abstract][Full Text] [Related]
23. The pathophysiology and burden of restenosis.
Weintraub WS
Am J Cardiol; 2007 Sep; 100(5A):3K-9K. PubMed ID: 17719351
[TBL] [Abstract][Full Text] [Related]
24. Long-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents.
Whan Lee C; Kim SH; Suh J; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
Catheter Cardiovasc Interv; 2008 Apr; 71(5):594-8. PubMed ID: 18311841
[TBL] [Abstract][Full Text] [Related]
25. Current treatment of in-stent restenosis.
Alfonso F; Byrne RA; Rivero F; Kastrati A
J Am Coll Cardiol; 2014 Jun; 63(24):2659-73. PubMed ID: 24632282
[TBL] [Abstract][Full Text] [Related]
26. Vascular restenosis - striving for therapy.
Schiele TM; Krötz F; Klauss V
Expert Opin Pharmacother; 2004 Nov; 5(11):2221-32. PubMed ID: 15500368
[TBL] [Abstract][Full Text] [Related]
27. Mesenchymal stem cells: a good candidate for restenosis therapy?
Forte A; Galderisi U; Cipollaro M; Cascino A
Curr Vasc Pharmacol; 2009 Jul; 7(3):381-93. PubMed ID: 19601863
[TBL] [Abstract][Full Text] [Related]
28. MicroRNAs for Restenosis and Thrombosis After Vascular Injury.
Gareri C; De Rosa S; Indolfi C
Circ Res; 2016 Apr; 118(7):1170-84. PubMed ID: 27034278
[TBL] [Abstract][Full Text] [Related]
29. Coronary restenosis: a review of mechanisms and management.
Rajagopal V; Rockson SG
Am J Med; 2003 Nov; 115(7):547-53. PubMed ID: 14599634
[TBL] [Abstract][Full Text] [Related]
30. Safety and efficacy of everolimus-eluting stents for bare-metal in-stent restenosis.
Ota H; Mahmoudi M; Torguson R; Satler LF; Suddath WO; Pichard AD; Waksman R
Cardiovasc Revasc Med; 2015; 16(3):151-5. PubMed ID: 25977226
[TBL] [Abstract][Full Text] [Related]
31. Optical coherence tomography (OCT) in PCI for in-stent restenosis (ISR): rationale and design of the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) study.
Adriaenssens T; Dens J; Ughi G; Coosemans M; Onsea K; Dubois C; Sinnaeve P; Vrolix M; Desmet W
EuroIntervention; 2011 May; 7 Suppl K():K100-5. PubMed ID: 22027717
[TBL] [Abstract][Full Text] [Related]
32. [Coronary restenosis].
Zotz RJ; Dietz U; Lindemann S; Genth-Zotz S
Herz; 2019 Feb; 44(1):35-39. PubMed ID: 30569181
[TBL] [Abstract][Full Text] [Related]
33. Activation of Peroxisome Proliferator-Activated Receptor-δ as Novel Therapeutic Strategy to Prevent In-Stent Restenosis and Stent Thrombosis.
Hytönen J; Leppänen O; Braesen JH; Schunck WH; Mueller D; Jung F; Mrowietz C; Jastroch M; von Bergwelt-Baildon M; Kappert K; Heuser A; Drenckhahn JD; Pieske B; Thierfelder L; Ylä-Herttuala S; Blaschke F
Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1534-48. PubMed ID: 27283742
[TBL] [Abstract][Full Text] [Related]
34. [Instent restenosis related to vessel injury score degree. Are current experimental models valid for drug-eluting stents analysis?].
Diego A; Pérez de Prado A; Cuellas C; Pérez-Martínez C; Gonzalo-Orden M; Altonaga JR; de Miguel A; Regueiro M; Ajenjo J; Sánchez-Lasheras F; Alvarez-Arenal A; Fernández-Vázquez F
Rev Esp Cardiol; 2011 Sep; 64(9):745-51. PubMed ID: 21700374
[TBL] [Abstract][Full Text] [Related]
35. Randomized trial of paclitaxel- versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: the ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) study.
Mehilli J; Byrne RA; Tiroch K; Pinieck S; Schulz S; Kufner S; Massberg S; Laugwitz KL; Schömig A; Kastrati A;
J Am Coll Cardiol; 2010 Jun; 55(24):2710-6. PubMed ID: 20226618
[TBL] [Abstract][Full Text] [Related]
36. Clinical and angiographic outcomes with sirolimus-eluting stents in total coronary occlusions: the ACROSS/TOSCA-4 (Approaches to Chronic Occlusions With Sirolimus-Eluting Stents/Total Occlusion Study of Coronary Arteries-4) trial.
Kandzari DE; Rao SV; Moses JW; Dzavik V; Strauss BH; Kutryk MJ; Simonton CA; Garg J; Lokhnygina Y; Mancini GB; Yeoh E; Buller CE;
JACC Cardiovasc Interv; 2009 Feb; 2(2):97-106. PubMed ID: 19463409
[TBL] [Abstract][Full Text] [Related]
37. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial.
Kastrati A; Mehilli J; von Beckerath N; Dibra A; Hausleiter J; Pache J; Schühlen H; Schmitt C; Dirschinger J; Schömig A;
JAMA; 2005 Jan; 293(2):165-71. PubMed ID: 15644543
[TBL] [Abstract][Full Text] [Related]
38. Edge vascular response after percutaneous coronary intervention: an intracoronary ultrasound and optical coherence tomography appraisal: from radioactive platforms to first- and second-generation drug-eluting stents and bioresorbable scaffolds.
Gogas BD; Garcia-Garcia HM; Onuma Y; Muramatsu T; Farooq V; Bourantas CV; Serruys PW
JACC Cardiovasc Interv; 2013 Mar; 6(3):211-21. PubMed ID: 23517830
[TBL] [Abstract][Full Text] [Related]
39. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K
Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925
[TBL] [Abstract][Full Text] [Related]
40. Impact of target lesion and nontarget lesion cardiac events on 5-year clinical outcomes after sirolimus-eluting or bare-metal stenting.
Chacko R; Mulhearn M; Novack V; Novack L; Mauri L; Cohen SA; Moses J; Leon MB; Cutlip DE
JACC Cardiovasc Interv; 2009 Jun; 2(6):498-503. PubMed ID: 19539252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
